Cargando…
Analysis of SOD2 rs4880 Genetic Variant in Patients with Alzheimer’s Disease
A few gene loci that contribute to Alzheimer’s Disease (AD) onset have been identified. Few studies have been published about the relationship between SOD2 rs4880 single nucleotide variant and AD, revealing inconsistent results. Therefore, the aim of the current study is to further examine the role...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9600469/ https://www.ncbi.nlm.nih.gov/pubmed/36286017 http://dx.doi.org/10.3390/cimb44100302 |
_version_ | 1784816850271469568 |
---|---|
author | Siokas, Vasileios Stamati, Polyxeni Pateraki, Georgia Liampas, Ioannis Aloizou, Athina-Maria Tsirelis, Daniil Nousia, Anastasia Sgantzos, Markos Nasios, Grigorios Bogdanos, Dimitrios P. Dardiotis, Efthimios |
author_facet | Siokas, Vasileios Stamati, Polyxeni Pateraki, Georgia Liampas, Ioannis Aloizou, Athina-Maria Tsirelis, Daniil Nousia, Anastasia Sgantzos, Markos Nasios, Grigorios Bogdanos, Dimitrios P. Dardiotis, Efthimios |
author_sort | Siokas, Vasileios |
collection | PubMed |
description | A few gene loci that contribute to Alzheimer’s Disease (AD) onset have been identified. Few studies have been published about the relationship between SOD2 rs4880 single nucleotide variant and AD, revealing inconsistent results. Therefore, the aim of the current study is to further examine the role of the SOD2 rs4880 in AD. We performed a case-control study with a total of 641 subjects (320 patients with probable AD, and 321 healthy controls). The statistical analysis was performed assuming five genetic models. The threshold for statistical significance was set at 0.05. The results revealed no association between SOD2 rs4880 and AD in any of the assumed genetic models that were examined [log-additive OR = 0.95 (0.76–1.19), over-dominant OR = 1.15 (0.85–1.57), recessive OR = 0.85 (0.59–1.22), dominant OR = 1.03 (0.72–1.47), and co-dominant OR1 = 1.10 (0.75–1.60) and OR2 = 0.90 (0.58–1.40)]. Adjustment for sex and subgroup analyses based on sex did not reveal any statistically significant results either. Based on our findings, SOD2 rs4880 does not appear to play a determining role in the risk of developing AD. Larger studies are warranted to elucidate the connection between rs4880 and AD. |
format | Online Article Text |
id | pubmed-9600469 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-96004692022-10-27 Analysis of SOD2 rs4880 Genetic Variant in Patients with Alzheimer’s Disease Siokas, Vasileios Stamati, Polyxeni Pateraki, Georgia Liampas, Ioannis Aloizou, Athina-Maria Tsirelis, Daniil Nousia, Anastasia Sgantzos, Markos Nasios, Grigorios Bogdanos, Dimitrios P. Dardiotis, Efthimios Curr Issues Mol Biol Article A few gene loci that contribute to Alzheimer’s Disease (AD) onset have been identified. Few studies have been published about the relationship between SOD2 rs4880 single nucleotide variant and AD, revealing inconsistent results. Therefore, the aim of the current study is to further examine the role of the SOD2 rs4880 in AD. We performed a case-control study with a total of 641 subjects (320 patients with probable AD, and 321 healthy controls). The statistical analysis was performed assuming five genetic models. The threshold for statistical significance was set at 0.05. The results revealed no association between SOD2 rs4880 and AD in any of the assumed genetic models that were examined [log-additive OR = 0.95 (0.76–1.19), over-dominant OR = 1.15 (0.85–1.57), recessive OR = 0.85 (0.59–1.22), dominant OR = 1.03 (0.72–1.47), and co-dominant OR1 = 1.10 (0.75–1.60) and OR2 = 0.90 (0.58–1.40)]. Adjustment for sex and subgroup analyses based on sex did not reveal any statistically significant results either. Based on our findings, SOD2 rs4880 does not appear to play a determining role in the risk of developing AD. Larger studies are warranted to elucidate the connection between rs4880 and AD. MDPI 2022-09-21 /pmc/articles/PMC9600469/ /pubmed/36286017 http://dx.doi.org/10.3390/cimb44100302 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Siokas, Vasileios Stamati, Polyxeni Pateraki, Georgia Liampas, Ioannis Aloizou, Athina-Maria Tsirelis, Daniil Nousia, Anastasia Sgantzos, Markos Nasios, Grigorios Bogdanos, Dimitrios P. Dardiotis, Efthimios Analysis of SOD2 rs4880 Genetic Variant in Patients with Alzheimer’s Disease |
title | Analysis of SOD2 rs4880 Genetic Variant in Patients with Alzheimer’s Disease |
title_full | Analysis of SOD2 rs4880 Genetic Variant in Patients with Alzheimer’s Disease |
title_fullStr | Analysis of SOD2 rs4880 Genetic Variant in Patients with Alzheimer’s Disease |
title_full_unstemmed | Analysis of SOD2 rs4880 Genetic Variant in Patients with Alzheimer’s Disease |
title_short | Analysis of SOD2 rs4880 Genetic Variant in Patients with Alzheimer’s Disease |
title_sort | analysis of sod2 rs4880 genetic variant in patients with alzheimer’s disease |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9600469/ https://www.ncbi.nlm.nih.gov/pubmed/36286017 http://dx.doi.org/10.3390/cimb44100302 |
work_keys_str_mv | AT siokasvasileios analysisofsod2rs4880geneticvariantinpatientswithalzheimersdisease AT stamatipolyxeni analysisofsod2rs4880geneticvariantinpatientswithalzheimersdisease AT paterakigeorgia analysisofsod2rs4880geneticvariantinpatientswithalzheimersdisease AT liampasioannis analysisofsod2rs4880geneticvariantinpatientswithalzheimersdisease AT aloizouathinamaria analysisofsod2rs4880geneticvariantinpatientswithalzheimersdisease AT tsirelisdaniil analysisofsod2rs4880geneticvariantinpatientswithalzheimersdisease AT nousiaanastasia analysisofsod2rs4880geneticvariantinpatientswithalzheimersdisease AT sgantzosmarkos analysisofsod2rs4880geneticvariantinpatientswithalzheimersdisease AT nasiosgrigorios analysisofsod2rs4880geneticvariantinpatientswithalzheimersdisease AT bogdanosdimitriosp analysisofsod2rs4880geneticvariantinpatientswithalzheimersdisease AT dardiotisefthimios analysisofsod2rs4880geneticvariantinpatientswithalzheimersdisease |